NO931627D0 - Heteroatomholdige tricykliske forbindelser, fremgangsmaatefor deres fremstilling og deres anvendelse som terapeutika - Google Patents

Heteroatomholdige tricykliske forbindelser, fremgangsmaatefor deres fremstilling og deres anvendelse som terapeutika

Info

Publication number
NO931627D0
NO931627D0 NO931627A NO931627A NO931627D0 NO 931627 D0 NO931627 D0 NO 931627D0 NO 931627 A NO931627 A NO 931627A NO 931627 A NO931627 A NO 931627A NO 931627 D0 NO931627 D0 NO 931627D0
Authority
NO
Norway
Prior art keywords
heteroatic
tricyclic
therapeutics
relations
procedure
Prior art date
Application number
NO931627A
Other languages
English (en)
Other versions
NO931627L (no
NO305865B1 (no
Inventor
Karl Baumann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO931627D0 publication Critical patent/NO931627D0/no
Publication of NO931627L publication Critical patent/NO931627L/no
Publication of NO305865B1 publication Critical patent/NO305865B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
NO931627A 1992-05-07 1993-05-05 Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser NO305865B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (3)

Publication Number Publication Date
NO931627D0 true NO931627D0 (no) 1993-05-05
NO931627L NO931627L (no) 1993-11-08
NO305865B1 NO305865B1 (no) 1999-08-09

Family

ID=26300836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931627A NO305865B1 (no) 1992-05-07 1993-05-05 Heteroatomholdige tricykliske forbindelser, farmas°ytisk preparat og anvendelse av slike forbindelser

Country Status (25)

Country Link
US (1) US5514685A (no)
EP (1) EP0569337B1 (no)
JP (1) JP2788392B2 (no)
KR (1) KR100292311B1 (no)
CN (1) CN1037773C (no)
AT (1) ATE155787T1 (no)
AU (1) AU668152B2 (no)
CA (1) CA2095659C (no)
CY (1) CY2126B1 (no)
CZ (1) CZ291773B6 (no)
DE (1) DE69312386T2 (no)
DK (1) DK0569337T3 (no)
ES (1) ES2105193T3 (no)
FI (2) FI102612B1 (no)
GR (1) GR3024754T3 (no)
HU (2) HUT66531A (no)
IL (1) IL105607A (no)
MY (1) MY109602A (no)
NO (1) NO305865B1 (no)
NZ (1) NZ247553A (no)
PH (1) PH30456A (no)
RU (1) RU2126009C1 (no)
SG (1) SG47011A1 (no)
SK (1) SK282061B6 (no)
TW (1) TW330936B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
PL184750B1 (pl) 1994-10-26 2002-12-31 Novartis Ag Kompozycja w postaci emulsji do stosowania miejscowego
PE52896A1 (es) 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
SI1064942T1 (en) 1998-03-26 2004-12-31 Fujisawa Pharmaceutical Co., Ltd. Sustained release preparation of a macrolide
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
EP2319493A3 (en) 2002-07-23 2011-07-27 Novartis AG Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
JP5739517B2 (ja) * 2010-04-02 2015-06-24 ヤンセン・アールアンドデイ・アイルランド 大環状インテグラーゼ阻害剤
CN107106588B (zh) 2014-10-28 2020-08-11 山口晃史 用于改善妊娠状态的药剂及其使用
US20210228551A1 (en) 2018-08-10 2021-07-29 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in maternofetal relationship
CN113226331A (zh) 2018-12-18 2021-08-06 山口晃史 用于改善不孕不育症或妊娠状态的药物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0364031B1 (en) * 1988-10-12 1992-12-23 Merck & Co. Inc. Hydroxide mediated fk-506 rearrangement process
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
AU641410B2 (en) * 1989-06-14 1993-09-23 Sandoz Ltd. Antiinflammatory and immunosuppressant triheterocyclic FK506-like compounds and processes for their preparation
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
DE69232630T2 (de) * 1991-09-05 2003-10-09 Abbott Lab Makrocyclische immunmodulatoren

Also Published As

Publication number Publication date
KR100292311B1 (ko) 2001-09-17
JP2788392B2 (ja) 1998-08-20
FI932035A0 (fi) 1993-05-05
SK282061B6 (sk) 2001-10-08
SG47011A1 (en) 1998-03-20
PH30456A (en) 1997-05-28
US5514685A (en) 1996-05-07
DE69312386T2 (de) 1998-01-29
FI932035A (fi) 1993-11-08
JPH0641144A (ja) 1994-02-15
CZ82993A3 (en) 1994-01-19
GR3024754T3 (en) 1997-12-31
HUT66531A (en) 1994-12-28
ATE155787T1 (de) 1997-08-15
CY2126B1 (en) 2002-06-21
IL105607A (en) 1998-01-04
FI102612B (fi) 1999-01-15
HU211135A9 (en) 1995-10-30
SK43593A3 (en) 1995-07-11
ES2105193T3 (es) 1997-10-16
CA2095659C (en) 2005-08-09
KR940005631A (ko) 1994-03-22
CN1037773C (zh) 1998-03-18
MY109602A (en) 1997-03-31
DK0569337T3 (da) 1998-01-19
TW330936B (en) 1998-05-01
NZ247553A (en) 1995-07-26
AU668152B2 (en) 1996-04-26
NO931627L (no) 1993-11-08
IL105607A0 (en) 1993-09-22
HU9301190D0 (en) 1993-07-28
DE69312386D1 (de) 1997-08-28
CZ291773B6 (cs) 2003-05-14
EP0569337A1 (en) 1993-11-10
AU3839393A (en) 1993-11-11
RU2126009C1 (ru) 1999-02-10
EP0569337B1 (en) 1997-07-23
FI102612B1 (fi) 1999-01-15
FI982476A0 (fi) 1998-11-16
NO305865B1 (no) 1999-08-09
CA2095659A1 (en) 1993-11-08
CN1083486A (zh) 1994-03-09

Similar Documents

Publication Publication Date Title
NO931627L (no) Heteroatomholdige tricykliske forbindelser, fremgangsmaatefor deres fremstilling og deres anvendelse som terapeutika
DE69319976T2 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
DK0618190T3 (da) 9-(Substitueret glycyl)amido-6-(substitueret)-5-hydroxy-6-deoxy-tetracycliner
PT626385E (pt) Derivados do tetra-hidropirano
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
EE9600057A (et) Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
NO178540C (no) Bisfenyletanderivater, farmasöytisk preparat derav samt anvendelse
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
DE69313931D1 (de) Polycyclische 31668P- und 31668U-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als antibiotische oder antitumorale Arzneistoffe
ES2053808T3 (es) Nuevos compuestos azolicos.
TH15136EX (th) อนุพันธ์ของไพราโซลซึ่งถูกแทนที่

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees